Subscribe
Subscribe
威高股份
医疗系统解决方案提供商
Shandong Weigao Group Medical Polymer Products Co. and its subsidiaries are principally engaged in the research and development, manufacture and sale of disposable medical devices. We provide different kinds of products, including: i) consumables (infusion sets, syringes, medical needle products, blood bags, pre-filled syringes, blood collection products and other consumables used); ii) bone materials and iii) blood purification consumables and equipment. The Company is the industrialization base of the achievements of the National High Technology Research and Development (863) Program of China, a national high-tech enterprise and a national enterprise technology center. The main production base of the Group is located in Weihai City, Shandong Province, the PRC.
医疗系统解决方案提供商
Shandong Weigao Group Medical Polymer Products Co. and its subsidiaries are principally engaged in the research and development, manufacture and sale of disposable medical devices. We provide different kinds of products, including: i) consumables (infusion sets, syringes, medical needle products, blood bags, pre-filled syringes, blood collection products and other consumables used); ii) bone materials and iii) blood purification consumables and equipment. The Company is the industrialization base of the achievements of the National High Technology Research and Development (863) Program of China, a national high-tech enterprise and a national enterprise technology center. The main production base of the Group is located in Weihai City, Shandong Province, the PRC.
GeneMind Biotech Closes Series B of CNY 140 Mn
Chinese Biotech Zai Laboratory Lands on HKEX after 3 Years' Listing on Nasdaq
AI-Based Drug Research Platform XtalPi Closes Series C at USD 318.8 Mn
Broncus Biotech Closes Series C of Multi-Tens Millions US Dollars
China's NMPA Reduces Paperwork for Inland Producers to Make Exotic Medical Devices
Top-Tier CDMO Heyuan China Closes Series C at over CNY 300 Mn
Tongshu Gene Closes Series B of Multi-Hundreds Millions
Medical Cosmetic Manufacture IMEIK Goes Public, Raising CNY 3.57 Bn
JD Health’s New Move on Hong Kong IPO
Biotech IMAB’s In-Process New Drug Enters Clinical Trials
3D Printing Precision Medicine Industry Park Lands in Hunan
Antibody Developer Biocytogen Closes Series D+ at CNY 790 Mn
Edge Medical Robotics Closes Pre Series B at Over CNY 100 Mn
Nasdaq-listed Biotech ZLAB Passes the Hearing for Hong Kong IPO
Genor Biopharma Passes the Hearing for Hong Kong IPO
WeChat’s Health Mini Program Has Access to Healthcare Reimbursement
Chunyu Doctor Closes Series E, Led-Invested by Sogou Technology
WeMed Secures CNY 100 Mn in Series C+ from GL Ventures
Singleron Biologics Receives USD 30 Mn in Series A for High-Throughput Sequencing
Surgical Robots Maker Jointech Closes Series B at Over CNY 100 Mn
EqualOcean is an international information service provider and investment research firm that aims to become a global platform for industrial innovation.
We strive to make technology inclusive, accessible and transparent.
Join over 70,000 of your peers
Beijing
9 Xiaguangli, 10F Block A CEC Development Mansion, Chaoyang Dc, Beijing 100125, China
Shanghai
A002, 5F, Ai Tower, 701 Yunjin Road, Xuhui Dc, Shanghai 200232, China
New York
800 Third Ave, 28F, New York, NY 10022, USA
Cooperation strategy
Products & prices
Customers & evaluation
